Increased dopamine and its receptor dopamine receptor D1 promote tumor growth in human hepatocellular carcinoma-Reference-Cited by-同舟云学术

Increased dopamine and its receptor dopamine receptor D1 promote tumor growth in human hepatocellular carcinoma

Published:2020-10-05 Issue:12 Volume:40 Page:694-710
ISSN:2523-3548
Container-title:Cancer Communications
language:en
Short-container-title:Cancer Communications

Author:

Yan Yan¹²,Pan Jiahao¹,Chen Yonghua³,Xing Wei¹,Li Qiang¹,Wang Dongyin¹,Zhou Xiaoshuang¹,Xie Jingdun¹,Miao Changhong⁴,Yuan Yunfei⁵,Zeng Weian¹,Chen Dongtai¹^ORCID

Affiliation:

1. Department of Anesthesiology Sun Yat‐Sen University Cancer Center State Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine Guangzhou Guangdong 510060 P. R. China

2. Department of Anesthesiology Huizhou Municipal Central Hospital Huizhou Guangdong 516001 P. R. China

3. Department of Anesthesiology Peking University Shenzhen Hospital Shenzhen Guangdong 518000 P. R. China

4. Department of Anesthesiology Fudan University Zhongshan Hospital Shanghai 20032 P. R. China

5. Department of Hepatobiliary Oncology Sun Yat‐Sen University Cancer Center State Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine Guangzhou Guangdong 510060 P. R. China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cac2.12103

Reference36 articles.

1. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017

2. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

3. A global view of hepatocellular carcinoma: trends, risk, prevention and management